Makers Laboratories Limited (BOM:506919)

India · Delayed Price · Currency is INR

207.30

+2.40 (1.17%)

At close: Oct 16, 2026

Market Cap	1.22B +56.4%
Revenue (ttm)	1.49B +17.8%
Net Income	34.19M -61.6%
EPS	5.79 -61.6%
Shares Out	5.90M
PE Ratio	35.77
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,227
Open	204.75
Previous Close	204.90
Day's Range	202.55 - 210.90
52-Week Range	109.00 - 236.55
Beta	0.22
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Makers Laboratories

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, dig... [Read more]

Industry Pharmaceutical Preparations

Founded 1984

Employees 114

Stock Exchange Bombay Stock Exchange

Ticker Symbol 506919

Full Company Profile

Financial Performance

In fiscal year 2026, Makers Laboratories's revenue was 1.41 billion, an increase of 16.30% compared to the previous year's 1.21 billion. Earnings were 23.51 million, a decrease of -68.61%.

Financial Statements